(Translation) 1/4 November 16, 2020 Re: Clarification of the operating results of company and its subsidiaries for the nine months period end September 30, 2020 To: President The Stock Exchange of

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to

Page 1 of 3 No. ACC6308/001 August 11, 2021 Subject: Clarification of the operating results quarter 2/2021 of the year ended June 30, 2021 Attention : Director and Managing Director, The Stock

. However, after the finish of the conclusion, the Company would comply furtherly with the disclosure in accordance with rules and regulations of the Stock Exchange of Thailand. 2. Total Liabilities and

: Management Discussion and Analysis for the year ended 31 December 2017 To : The President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the year ended 31

President The Stock Exchange of Thailand Takuni Group Public Company Limited (“The Company”) and its subsidiaries (“The Group”) would like to clarify the change in operating result for the period ended 30

-Translation- No. ECF2 010/2019 February 27, 2019 Subject: Management Discussion and Analysis of the year ended December 31, 2018 To President The Stock Exchange of Thailand East Coast Furnitech

Microsoft Word - MD&A FY17 EN (1) February 26, 2018 To President, The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20

แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 WHAUP 008/2018 February 20, 2018 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for the Year